Although diffuse glioma is often described as a network-level brain disease, the tract-wise FA findings in our cohort point to selective, left-hemispheric changes associated with EGFR amplification (AF and FAT), rather than diffuse whole-brain involvement [29]. This evidence concerns the gene EGFR and brain disorder.